Inactive Instrument

News IMV Inc. Toronto S.E.

Equities

IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets	23-09-04	AQ
Transcript : IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023	23-03-16
Transcript : IMV Inc., Q3 2022 Earnings Call, Nov 11, 2022	22-11-11
Transcript : IMV Inc., Q2 2022 Earnings Call, Aug 11, 2022	22-08-11
Transcript : IMV Inc. - Shareholder/Analyst Call	22-06-29
IMV Inc. : to Present at Two Upcoming Investor Conferences	19-06-13	BU
Imv : New Phase 2 Clinical Trial Results Continue to Demonstrate Potential Clinical Benefit of IMV’s DPX-Survivac in Combination with Merck’s Keytruda in Patients with DLBCL	19-06-12	BU

No results for this search